跳至主要内容
临床试验/NCT04548778
NCT04548778已完成不适用

Clinical Evaluation of BÜHLMANN Fecal Pancreatic Elastase (fPELA) Tests in the Diagnosis of Exocrine Pancreatic Insufficiency (PEI)

Bühlmann Laboratories AG1 个研究点 分布在 1 个国家目标入组 201 人开始时间: 2020年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
201
试验地点
1
主要终点
Clinical Performance of BÜHLMANN fPELA assays in the diagnosis of PEI

研究概览

简要总结

The study shall determine the clinical performance of the BÜHLMANN fecal pancreatic elastase (fPELA) assays in the diagnosis of exocrine pancreatic insufficiency (PEI).

This is a observational and cross-sectional performance study. Specimens and clinical data are collected by a single study site.

Included are subjects for which pancreatic elastase testing was indicated due to a suspected exocrine pancreatic insufficiency and which were at least 18 years of age. Subjects which suffered from diarrhea (stool water content ≥ 75%) at the time of sample collection are excluded from the study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • suspected exocrine pancreatic insufficiency
  • at least 18 years of age.

排除标准

  • diarrhea (stool water content ≥ 75%) at the time of sample collection

结局指标

主要结局

Clinical Performance of BÜHLMANN fPELA assays in the diagnosis of PEI

时间窗: December 2021

Diagnostic sensitivity and specificity of BÜHLMANN fPELA assays

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验